1. Volume 141, Issue 4, Pages 1212-1219 (October 2011)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation 
James Fung, Cindy Cheung, See–Ching Chan, Man–Fung Yuen, Kenneth S.H. Chok, William Sharr, Wing–Chiu Dai, Albert C.Y. Chan, Tan–To Cheung, Simon Tsang, Banny Lam, Ching–Lung Lai, Chung–Mau Lo 
Gastroenterology 
Volume 141, Issue 4, Pages (October 2011)
DOI: /j.gastro
Copyright © 2011 AGA Institute Terms and Conditions

2. Figure 1
(A) Cumulative rate of HBsAg seroclearance. (B) Cumulative rate of HBsAg seroclearance in patients with and without HBV DNA level <5 log copies/mL and HBsAg level <3 log IU/mL. (C) Cumulative rate of HBsAg seroclearance in patients with and without detectable anti-HBs after liver transplant. (D) Cumulative rate of HBsAg relapse after initial seroclearance.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions

3. Figure 2
Levels of HBV DNA at the time of liver transplant and at 1 to 3, 6, 12, and 24 months after transplant.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2011 AGA Institute Terms and Conditions